SCHEMBL273688

SCHEMBL273688

COc1ccc(Oc2cccc(C=O)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.65
RAB9A P51151 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
ALDH1A1 P00352 4/20 0.57
CYP2A6 P11509 1/20 0.57
RELA Q04206 1/20 0.56
LTA4H P09960 1/20 0.53
TTR P02766 1/20 0.53
ADAMTS5 Q9UNA0 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
MAOB P27338 4/20 0.49
KDM4E B2RXH2 1/20 0.49
HTT P42858 1/20 0.49
SRC P12931 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
CHRM5 P08912 1/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30866102 1.00 NPC1 (0.65) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL17099392 0.91 NPC1 (0.58) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL6856729 0.91 SRC (0.56) NPC1RAB9ATDP1ALDH1A1TTR
Glycine SCHEMBL8204567 0.87 NPC1 (0.56) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL7798169 0.87 NPC1 (0.63) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL31599170 0.87 SRC (0.53) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL6853633 0.87 SRC (0.53) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL11222905 0.87 MAOB (0.59) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL23188 0.87 NPC1 (0.65) NPC1RAB9ATDP1ALDH1A1CYP2A6
SCHEMBL7684603 0.87 NPC1 (0.65) NPC1RAB9ATDP1ALDH1A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084176-A1 Detection of uronium salts YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2006-04-20 US claimed
US-20040132807-A1 Aurones as telomerase inhibitors PHARMACIA ITALIA SPA (IT) 2004-07-08 US claimed
EP-1381359-A1 AURONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-21 EP claimed
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments ALLERGAN, INC. 2003-07-03 US claimed
WO-2002083123-A1 AURONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-10-24 WO claimed
WO-2024100526-A1 SMART BIOSTIMULANT DELIVERY FOR PLANT GROWTH AND DEVELOPMENT KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2024-05-16 WO disclosed
CN-117844007-A Sp (sp) 2 Preparation method of carbon conjugated two-dimensional polymer film 中国科学院宁波材料技术与工程研究所 2024-04-09 CN disclosed
US-20220400669-A1 COMPOUNDS AND METHODS FOR PROMOTING PLANT GROWTH KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2022-12-22 US disclosed
US-20220400669-A1 COMPOUNDS AND METHODS FOR PROMOTING PLANT GROWTH KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2022-12-22 US disclosed
CN-110835335-B 2, 5-diketopiperazine compound and application thereof in preparation of anti-cancer drugs 深圳华大海洋科技有限公司 2022-04-15 CN disclosed
US-20220022395-A1 JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENY TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2022-01-27 US disclosed
EP-3903576-A1 JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENY Tokyo University of Science Foundation (JP) 2021-11-03 EP disclosed
US-5171882-A Leukotriene antagonists ELI LILLY AND COMPANY (US) 1992-12-15 US disclosed
US-4992576-A Antiinflammatory, antiallergens ELI LILLY AND COMPANY (US) 1991-02-12 US disclosed
EP-0276064-B1 ANTI-INFLAMMATORY AGENTS ELI LILLY AND COMPANY (US) 1990-10-31 EP disclosed
EP-0276064-A1 Anti-inflammatory agents ELI LILLY AND COMPANY (US) 1988-07-27 EP disclosed
US-4371607-A 4-Halogeno-5-(halogenomethyl-phenyl)-oxazole derivatives, a process for the preparation thereof, and radiation-sensitive compositions containing these derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-01 US disclosed
EP-0041675-A2 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them HOECHST AKTIENGESELLSCHAFT (DE) 1981-12-16 EP disclosed
US-4220767-A HISTAMINE ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-09-02 US disclosed
US-4185103-A ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments TYR, ALDH2, AOX1 NPC1 2414/4885RAB9A 4397/4885TDP1 809/4885
US-20220022395-A1 JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENY MYB, ERO1A, ERG28 NPC1 3067/4885RAB9A 1920/4885TDP1 3803/4885
US-20040132807-A1 Aurones as telomerase inhibitors TERT, TERF2, TERF2IP NPC1 2706/4885RAB9A 3258/4885TDP1 13/4885
US-20220400669-A1 COMPOUNDS AND METHODS FOR PROMOTING PLANT GROWTH NR5A1, GHITM, AREG NPC1 2351/4885RAB9A 4299/4885TDP1 4523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.